Home » Stocks » NTUS

Natus Medical Incorporated (NTUS)

Stock Price: $26.71 USD -0.91 (-3.29%)
Updated Apr 22, 2021 4:00 PM EDT - Market closed
Market Cap 973.58M
Revenue (ttm) 415.68M
Net Income (ttm) -16.61M
Shares Out 33.56M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 22
Last Price $26.71
Previous Close $27.62
Change ($) -0.91
Change (%) -3.29%
Day's Open 27.74
Day's Range 26.66 - 27.85
Day's Volume 183,437
52-Week Range 16.38 - 28.83

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

Other stocks mentioned: ABT, AMEH, HSIC, NDRA, OMI, PEN
6 days ago - Zacks Investment Research

PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

2 weeks ago - GlobeNewsWire

PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...

3 weeks ago - GlobeNewsWire

It is imperative to build a portfolio of low-beta stocks to sail through the choppy market. RCKY, STMP, OMI, NTUS & TM are the frontrunners.

Other stocks mentioned: OMI, RCKY, STMP, TM
3 weeks ago - Zacks Investment Research

3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

Other stocks mentioned: ABMD, HOLX, IDXX, ISRG, TMO
3 weeks ago - Zacks Investment Research

Low-beta stocks may be able to help sail through the choppy market conditions.

Other stocks mentioned: OMI, PEN, RCKY, RGR
1 month ago - Zacks Investment Research

To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.

Other stocks mentioned: OMI, RGR, TM
1 month ago - Zacks Investment Research

Natus Medical (NTUS) delivered earnings and revenue surprises of 62.50% and 0.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

PLEASANTON, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...

1 month ago - GlobeNewsWire

Natus Medical (NASDAQ:NTUS) announces its next round of earnings this Thursday, February 25. Here is Benzinga's look at Natus Medical's Q4 earnings report.

1 month ago - Benzinga

PLEASANTON, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...

3 months ago - GlobeNewsWire

PLEASANTON, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

3 months ago - GlobeNewsWire

PLEASANTON, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tr...

4 months ago - GlobeNewsWire

PLEASANTON, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...

4 months ago - GlobeNewsWire

Natus Medical (NTUS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

5 months ago - Zacks Investment Research

Natus Medical (NTUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 months ago - Zacks Investment Research

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Natus Medical (NTUS) delivered earnings and revenue surprises of 800.00% and 8.90%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

PLEASANTON, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...

5 months ago - GlobeNewsWire

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

PLEASANTON, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

6 months ago - GlobeNewsWire

PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and...

7 months ago - GlobeNewsWire

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Natus Medical (NTUS) delivered earnings and revenue surprises of -360.00% and -13.67%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

PLEASANTON, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...

8 months ago - GlobeNewsWire

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

PLEASANTON, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...

10 months ago - GlobeNewsWire

What should investors think of this infant care and neurology specialist?

10 months ago - The Motley Fool

Partnership to advance the development and distribution of innovative AutoSCORE algorithm Partnership to advance the development and distribution of innovative AutoSCORE algorithm

11 months ago - GlobeNewsWire

PLEASANTON, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...

1 year ago - GlobeNewsWire

Another key partner joins the Otocloud community, expanding the reach even further.

1 year ago - GlobeNewsWire

PLEASANTON, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...

1 year ago - GlobeNewsWire

About NTUS

Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and n... [Read more...]

Industry
Medical Devices
Founded
1987
CEO
Jonathan Kennedy
Employees
1,420
Stock Exchange
NASDAQ
Ticker Symbol
NTUS
Full Company Profile

Financial Performance

In 2020, Natus Medical's revenue was $415.68 million, a decrease of -16.05% compared to the previous year's $495.18 million. Losses were -$16.61 million, 6.01% more than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Natus Medical is 36.00, which is an increase of 34.78% from the latest price.

Price Target
$36.00
(34.78% upside)